Good News At The Earliest: Fair Distribution Of COVID-19 Vaccine

Now talk of the world is the COVID-19 vaccine at the earliest and put an end to the pandemic situation and get back to normal life.But for now we are in better than worst position because many companies are working on vaccine development, either on their own or in collaboration, all the country is working towards finding vaccines. The pandemic has exacerbated inequalities, and it has proved to be a learning opportunity to improve resilience and strengthen public health systems.

Coronavirus is a family of viruses that can cause a range of illnesses in humans including common cold and more severe forms like SARS and MERS which are life-threatening. The virus is named after its shape which takes the form of a crown with protrusions around it and hence is known as corona-virus. Now, getting used to this new normal life is essential.

Symptoms of COVID19:

Most people infected with the COVID-19 virus initially will experience mild to moderate respiratory illness. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness and will take more time to get recovered from the illness.

The best way to prevent and slow down transmission is be well informed about the COVID-19 virus, the disease it causes and how it spreads. Protect yourself and others from infection by washing your hands or using an alcohol-based rub frequently and wear the mask.

Generally, the COVID-19 virus spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes, so it’s important that you also practice respiratory etiquette (for example, by coughing into a flexed elbow). At this time, there are no specific vaccines or treatments for COVID-19. However, there are many ongoing clinical trials evaluating potential treatments.

Finding vaccine at the earliest:

At present the focus needs to be on global collaboration when dealing with the virus diagnostics, therapeutics, behavioural and mental health concerns, transmission, vaccine development, and how the disease impacts the life of humans. Next ‘real’ supply chain crisis however will be to vaccinate the whole world, safely, efficiently and fairly. We have to get from formulating, to planning, to manufacturing and finally distributing billions of doses of vaccine.

As for the present situation we struggle to flatten the curve of the pandemic, persistently scientists are working towards the development of a vaccine. But the challenge of creating and approving a vaccine is only the first step towards vaccinating everyone in the world. The production and distribution of hundreds of millions of doses, when a vaccine is approved, is yet another challenge that must be overcome. Once the vaccine is on the market, every country in the world will want it—and there will be almost 8 billion consumers by then.

Before finding the vaccine, the vaccine supply chain will also include not only the development and production of the vaccine content, but also the storage and packaging of components, cold chain transit, and national and global shipping. Also, Pharmaceuticals must be kept at a certain temperature.

Fighting the Coronavirus with innovative tech:

The Italian hospital chain has adopted an innovative technology to combat the COVID-19 pandemic. These include robotic dogs that monitor parks for social distancing, thermal sensors that detect fevers from 10 feet away, and hand-washing sensors are being utilized.

The ADDAMS robot, developed at the Viterbi School of Engineering at the University of Southern California, goes one step further. It is equipped with a Universal Robots arm that can pick up items, open drawers, move objects, and even open and close doors remotely while disinfecting the room with UV light and chemical hydrogen peroxide spray. The technology development lead to solution in fight against this virus, and would end this crisis and give a better solution in the upcoming days.

Approval of a Coronavirus Vaccine Would Be Just the Beginning:

Developing a new vaccine is only the first part of the complex journey that’s supposed to end with a return to some sort of normal life. Producing billions for the world as a whole – will be no small feat. There are many technical and economic challenges that will need to be overcome somehow to produce millions of vaccines as fast as possible. The issues the world is facing today regarding the coronavirus vaccine are not new, but the stakes are perhaps higher than ever before.

“It is of course important when you consider the vaccination of people to immunize against coronavirus. It needs to work. It needs to be widespread. There needs to be scientific confidence that this will work. Of course, that is important which is why I think the UK government and others are being cautious not to promise anything at this stage. And that means that as we speak now there need to be real efforts made to control the spread of the virus rather than relying on a vaccine which of course will happen sooner rather than later but until such a time our efforts must be to control the spread of the virus”says Dr.Chaand Nagpaul.

“The idea that there would be resistance to what might potentially turn [the pandemic] around seemed a little bit unlikely, but obviously I did not properly understand the groundswell of resistance that is now out there,” Dr. Collins said in an interview.To all the questions and doubts the only solution is the finding of the vaccine and put a full stop to this pandemic situation.

At the end we all know COVID-19 is one of the deadly viruses for which finding vaccine would take a decade and we have to learn to live with it with protection and care. The question ultimately falls on the hands of us (humans).Even the suggestion that a vaccine will be developed and available in the next several months has led many to underestimate the virus, both in terms of its immediate malicious effects and its potential to infect an even wider spectrum of the global population ,because we really don’t know the exact nature of the virus and it really needs some more time for observation. There have been so many theoretically proven situations but we can’t risk human’s lives for practical testing. Hence, we need to wait for some more time until a permanent proven solution is provided.

“Distributing COVID-19 vaccine all over the world pretty without letting the wealthy nations nook the restricted doses goes to be a big problem”, says the World Health Organization’s Chief Scientist Soumya Swaminathan.   

“By early 2021, we should have some good news.”